Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1500
+0.0150 (11.11%)
At close: Feb 27, 2026
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 20.28 million as of March 2, 2026. Its market cap has decreased by -21.06% in one year.
Market Cap
20.28M
Enterprise Value
25.93M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 20.28M, a decrease of -68.20%. That is a compound annual growth rate of -14.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 20.28M | 14.87% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 33.88M |
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 29.90M |
| Thiogenesis Therapeutics | 29.03M |
| Quantum BioPharma | 18.83M |
| Hemostemix | 16.60M |
| Britannia Life Sciences | 15.41M |
| Lobe Sciences | 14.82M |